Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 9/30251% above fair value
$4.65−0.13 (-2.72%)
Close on Nov 12, 2026Market cap $64.72MP/E –Yield –
Champions Oncology statistics
86 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Dec 14, 2026 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jul 31, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 18.19
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 1.00
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- -1.20%
- 10.9%
- Shares Change (QoQ)
- 0.23%
- 0.48%
- Float
- 10M
- 49M
- Shares Held by Insiders
- 30.5%
- 12.1%
- Shares Held by Institutions
- 42.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 72,290
- –
- Short Interest Change
- -6.90%
- -0.76%
- Short % of Float
- 0.75%
- 9.06%
- Short % of Shares Outstanding
- 0.52%
- 6.30%
- Days to Cover
- 8.55
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $8.31
- –
- 52-Week Low
- $4.59
- –
- 20-Day Moving Average
- $4.79
- –
- 50-Day Moving Average
- $4.91
- –
- 200-Day Moving Average
- $5.64
- –
- Average True Range (14)
- $0.19
- –
- Price Change (1 Week)
- -2.31%
- 1.51%
- Price Change (1 Month)
- -3.33%
- -2.37%
- Price Change (3 Months)
- -8.19%
- -21.1%
- Price Change (6 Months)
- -25.1%
- -22.8%
- Price Change (YTD)
- -32.7%
- -22.6%
- Price Change (1 Year)
- -33.6%
- -21.0%
- Price Change (3 Years)
- -15.0%
- -24.8%
- Price Change (5 Years)
- -52.9%
- -76.9%
- Price Change (10 Years)
- 159.8%
- -63.2%
- Average Volume (10 Days)
- 6,922
- –
- Average Volume (20 Days)
- 7,733
- –
- Average Volume (90 Days)
- 10,259
- –
- Relative Volume
- 0.38
- 0.80
- Relative Strength Index (14)
- 39.7
- 44.7
- Volatility (1 Year)
- 53.3%
- 80.2%
- Beta (5 Years)
- 0.36
- 1.07
MarginsIndustry
- Pretax Margin
- -1.47%
- -11.8%
- EBITDA Margin
- 0.48%
- -27.7%
- FCF Margin
- -10.1%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- -29.8%
- -51.3%
- Return on Assets (ROA)
- -3.46%
- -40.7%
- Return on Capital Employed (ROCE)
- -7.02%
- -38.1%
Financial positionIndustry
- Current Ratio
- 1.03
- 3.31
- Quick Ratio
- 0.96
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 6.65%
- 7.26%
- Net Income Growth (YoY)
- -137.8%
- -14.4%
- EPS Growth (YoY)
- -140.0%
- -11.7%
- FCF Growth (YoY)
- -184.8%
- 7.48%
- Revenue Growth (3Y CAGR)
- 3.33%
- 2.25%
- Revenue Growth (5Y CAGR)
- 7.68%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.90
- 0.40
- Revenue Per Employee
- $283.46K
- $429.38K
- Profits Per Employee
- -$5.16K
- -$683.67K
- Employee Count
- 214
- 75
- WACC
- 7.38%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$892.00K
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $4.36M
- $16.98M
- Net Cash Per Share
- $0.31
- $0.72
- Equity (Book Value)
- $3.89M
- $52.68M
- Book Value Per Share
- $0.28
- $1.50
- Tangible Book Value
- $3.56M
- $26.74M
- Working Capital
- $563.00K
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$573.00K
- -$944.00K
- FCF Per Share
- -$0.44
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -1.71%
- -21.0%
- FCF Yield
- -9.48%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $243.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.34
- 0.26
- Piotroski F-Score
- 3
- 4
- Beneish M-Score
- -1.80
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CSBR | S&P 500 | Difference | CSBR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.1% | -2.7% | −3.4 pts | ||
| 3 months | -6.1% | -1.7% | −4.3 pts | ||
| Year to date | -32.7% | +11.9% | −44.6 pts | ||
| 1 year | -32.3% | +12.0% | −44.3 pts | ||
| 3 years | -16.7% | +78.2% | −94.8 pts | -5.9% | +21.2% |
| 5 years | -52.9% | +73.2% | −126.2 pts | -14.0% | +11.6% |
| 10 years | +159.8% | +309.6% | −149.9 pts | +10.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CSBR shares were sold short on Oct 30, 2026, down 6.9% from the previous report, or 0.75% of the shares available to trade. At recent volumes it would take 8.6 days to buy them back. Over the last 20 sessions, 34.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 72,290 | -6.9% | 8,455 | 8.6 |
| Oct 15, 2026 | 77,651 | +9.4% | 8,271 | 9.4 |
| Sep 30, 2026 | 70,961 | +3.6% | 16,142 | 4.4 |
| Sep 15, 2026 | 68,463 | -7.8% | 12,394 | 5.5 |
| Aug 31, 2026 | 74,290 | +0.4% | 6,176 | 12.0 |
| Aug 14, 2026 | 73,998 | -2.8% | 12,386 | 6.0 |
| Jul 31, 2026 | 76,164 | +0.8% | 8,466 | 9.0 |
| Jul 15, 2026 | 75,566 | -1.8% | 9,624 | 7.8 |
| Jun 30, 2026 | 76,917 | -2.1% | 7,359 | 10.4 |
| Jun 15, 2026 | 78,531 | -2.6% | 6,241 | 12.6 |
| May 29, 2026 | 80,601 | -4.9% | 12,245 | 6.6 |
| May 15, 2026 | 84,726 | +1.2% | 11,179 | 7.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?